top of page
Transforming healthcare through detection and regenerative therapeutics
At YD Bio, we focus on developing innovative solutions across two areas of urgent medical need: non-invasive early cancer detection and regenerative approaches for eye health. By pursuing cutting-edge science in both oncology and ophthalmology, we aim to improve quality of life, deliver earlier insights into disease, and create new possibilities for patients worldwide.
DNA Methylation Detection
Earlier detection. Improved outcomes.
Through proprietary DNA methylation analysis, we are developing non-invasive blood tests that help clinicians detect cancer earlier, monitor treatment response, and track recurrence risk. These tools are designed to give physicians actionable insights at every stage of care, supporting more effective, personalized treatment for patients.
Exosome-Based Ophthalmology Therapeutics
Regenerative science for eye health.
Exosomes are natural messengers that can help repair and restore cellular function. At YD Bio, we are advancing exosome-based therapies to address large unmet needs in ophthalmology, including chronic conditions such as dry eye. By leveraging regenerative science, our goal is to deliver long-term solutions that improve patient comfort, vision, and quality of life.
bottom of page